|
Market Cap (5-Jun) $55,535,856 (1,270th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 227,504 |
Shortsold (18-Aug) 146,107 (0.01%) (520th) |
|
52w High $0.045 |
52w Low $0.040 |
P/E - |
EPS 0.03 |
DNA released this announcement to the ASX on 30 August 2022, 17:54. The announcement is not marked as price sensitive, and is 20 page(s) in length and 452.48kb in size.
You can view all announcements from DNA and see how they appear on a price chart on the announcements page.
At the date of this announcement, DNA was 0.012% short sold according to ASIC data. It was ranked the 520th most shorted stock on the ASX. It remains ranked 520th as of the latest reported data (18 August 2025).
| Other Recent Announcements from DNA | |
|---|---|
| Quarterly Activities Report | 28 April 2023, 16:17 |
| Appendix 4C Cash Flow Report | 28 April 2023, 16:15 |
| 1H FY23 Results Summary | 1 March 2023, 8:45 |
| Appendix 4G and FY22 Corporate Governance Statement | 30 August 2022, 17:54 |
| FY22 Results Presentation | 30 August 2022, 17:51 |
| FY22 Results Commentary | 30 August 2022, 17:51 |
| Preliminary Final Report | 30 August 2022, 17:49 |
You must be logged in to post a reply.
Donaco International 